Thursday, July 26, 2012
The California stem cell agency today cleared the way for approval of an $18 million grant to develop a new cell-based therapy for treatment of ALS.
The agency's governing board moved the application into a category that is expected to approved later today.
The action came on an appeal by researcher Clive Svendsen of Cedars Sinai. Also supporting the application were a number of persons with ALS.Sphere: Related Content